Danish investigators conducted a cohort study to assess the impact of low-dose aspirin on lower gastrointestinal bleeding, colorectal bleeding, and colorectal polyps.
Some guidelines suggest colorectal cancer (CRC) screening by age 50 for African Americans, but data on screening uptake and yield among this population is limited.
Researchers assert that PAs will play a key role in expanding access to colonoscopies for patients as a result of their comparable performance with attending physicians.
Exact risk-adapted starting ages for CRC could be used to better counsel individuals about the appropriate age to be screened.
Researchers sought to determine the 10-year risk for developing advanced neoplasia and assessed whether baseline colonoscopy findings were associated with long-term outcomes.
The US Multi-Society Task Force released updated recommendations for postcolonoscopy management strategies and polyp surveillance.
Researchers concluded that bariatric surgery is strongly associated with an increased risk for colon cancer, though further research may be needed to establish an association between bariatric surgery and an increased risk for rectal cancer.
Risk increased for colon cancer 10 to 14 years after surgery; no increase in risk found for rectal cancer.
The omega-3 polyunsaturated fatty acid eicosapentaenoic acid and aspirin were compared alone and in combination against placebo for the prevention of colorectal cancer.
Diagnosing, but leaving these polyps can save time and, likely, costs.
